Schizophrenia and neurotransmission: An excess of analogous drug treatment?;Schizophrenie et neurotransmission: Un exces de traitement analogique?

Encephale

Volumn 22, Issue SPEC. ISS. 3, 1996, Pages 91-98

  Tassin, J P ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUTAMIC ACID; NORADRENALIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NEUROLEPTIC AGENT;

CONFERENCE PAPER; HUMAN; NEUROTRANSMISSION; PREFRONTAL CORTEX; SCHIZOPHRENIA; BRAIN; BRAIN MAPPING; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; REVIEW; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BRAIN; BRAIN MAPPING; HUMANS; NEUROTRANSMITTER AGENTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 0029818272     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. ABERCROMBIE ED, JACOBS BL. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and non stressful stimuli. J Neurosci 1987 ; 7 : 2837-43.
2. ALEXANDER GE, CRUTCHER MD. Functional architecture of basal ganglia circuits : neural substrates of parallel processing. Trends in Neurosci 1990; 13: 266-71.
3. ASTON-JONES G, BLOOM FE. NE-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci 1981 ; 1 : 887-900.
4. BARUCH I, HEMSLEY DR, GRAY JA. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis 1988 ; 176: 598-606.
5. BERGER PA, FAULL KF, KILKOWSKI J et al. CSF monoamine metabolites in depression and schizophrenia. Am J Psychiatry 1980 ; 137: 174-80.
6. BLANC G, TROVERO F, VEZINA P et al. Blockade of prefronto-cortical alpha 1 -adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Europ J Neurosci 1994 ; 6 : 293-8.
7. BLOOM FE. Central noradrenergic systems : Physiology and pharmacology. In : Psychopharmacology-A generation of Progress, Lipton ME, Killam KC, DiMascio A, eds. New-York : Raven Press, 1978 : 131.
8. BROZOSKI TJ, McBROWN R, ROSVOLD HE, GOLDMAN PS. Cognitive deficit caused by regional depletion of dopa-mine in prefrontal cortex of rhesus monkey. Science 1979 ; 205 : 929-32.
9. CARLSSON A, LINDQVIST M. Effect of chlorpromazine or haloperidol on formation of 3H-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 1963 ; 20 : 140-4.
10. CONNELL PH. Amphetamine psychosis. London : Chapman & Hall, 1958.
11. COTMAN CW, MONAGHAN DT. Excitatory amino acid neurotransmission : NMDA receptors and Hebb-type synaptic plasticity. Ann Rev Neurosci 1988 ; 11 : 61-80.
12. CUTTING J. The psychology of schizophrenia. Livingstone : Churchill, 1985.
13. DE LA CASA LG, RUIZ G, LUBOW RE. Latent inhibition and recall/recognition of irrelevant stimuli as a function of pre-exposure duration in high and low psychotic-prone normal subjects. Br J Psychol 1993; 84 (Pt1): 119-32.
14. DIVAC I, FONNUM F, STORM-MATHISEN J. High affinity uptake of glutamate in terminals of corticostriatal axons. Nature (London) 1978 ; 266 : 377-8.
15. FRITH CD. Consciousness, information processing, and schizophrenia. Br J Psychiatry 1979 ; 134 : 225-35.
16. FUSTER JM. A theory of prefrontal functions : the prefrontal cortex and the temporal organization of behaviour. In : The prefrontal cortex : anatomy, physiology, and neuropsychology of the frontal lobe. (Second edition). New-York : Raven Press, 1988 : 157-92.
17. GOMEZ UCR, SHANKEY BC, POTGIETER L, ROUX JT. Noradrenergic overactivity in chronic schizophrenia : evidence based on cerebrospinal fluid and cyclic nucleotide concentrations. Brit J Psychiatry 1980 ; 137 : 346-51.
18. GRACE AA. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity : a hypothesis for the etiology of schizophrenia. Neuroscience 1991 ; 41 : 1-24.
19. GRACE AA, BUNNEY BS. The control of firing pattern in nigral dopamine neurons : single spike firing. J Neurosci 1984 ; 4 : 2866-76.
20. GRACE AA, BUNNEY BS. The control of firing pattern in nigral dopamine neurons, burst firing. J Neurosci 1984b ; 4 : 2877-90.
21. GRACE AA, BUNNEY BS. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol : analysis using in vivo intracellular recording. J Pharmac Exp Ther 1986 ; 238 : 1092-100.
22. GRAY JA, FELDON J, RAWLINS JNP et al. The neuropsychology of schizophrenia. Behav and Brain Sci 1991 ; 14 : 1-84.
23. HEBB DO. Organization of behaviour. New-York : Wiley, 1949.
24. HEMSLEY DR. An experimental psychological model for schizophrenia. In : Search for the causes of schizophrenia, Hafner H, Gattaz WF & Janzavik W, eds. Springer Verlag, 1987.
25. HONDO H, YONEZAWA Y, NAKAHARA T et al. Effect of phencyclidine on dopamine release in the rat prefrontal cortex ; an in vivo microdialysis study. Brain Res 1994 ; 633 : 337-42.
26. HOPFIELD JJ. Neural networks and physical systems with emergent collective computational abilities. Proc Natl Acad Sci, USA 1982 ; 79 : 2554-8.
27. HOPFIELD JJ, TANK DW. Computing with neural circuits. Science 1986 ; 233 : 625-33.
28. INGVAR DH, FRANZEN G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974 ; 50 : 425-62.
29. JACOBSEN CF, NISSEN HW. Studies of cerebral function in primates. IV. The effects of frontal lobe lesions on the delayed alternation habit in monkey. J Comp Physiol Psychol 1937 ; 23 : 101-12.
30. JAVITT DC. Negative symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside. J Clin Psychiatry 1987 ; 9 : 12-35.
31. KELLY PH, SEVIOUR PW, IVERSEN SD. Amphetamine and apomorphine responses in the rat following 6-OHDA lesion of the nucleus accumbens septi and corpus striatum. Brain Res 1975 ; 94 : 507-23.
32. KEMALI D, DELVECCHIO M, MAJ M. Increased noradrenaline levels in CSF and plasma of schizophrenic patients. Biol Psychiatry 1982 ; 17 : 711-7.
33. LAKE CR, STERNBERG DE, VAN KAMMEN DP et al. Schizophrenia : elevated cerebrospinal fluid norepinephrine. Science 1980 ; 207 : 331-3.
34. MAGARO PA. Psychosis and schizophrenia. In : Theories of schizophrenia and psychosis, Spaulding WD & Cole JK, eds. University of Nebraska Press, 1984.
35. McGEER PL, McGEER EG, SCHERER U, SINGH K. A glutamatergic corticostriatal path ? Brain Res 1977 ; 128 : 369-73.
36. McGEORGE AJ, FAULL RLM. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 1989 ; 29 : 503-37.
37. MITA T, HANADA S, NISHINO N et al. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 1986 ; 21 : 1407-14.
38. MURASE S, GRENHOFF J, CHOUVET G et al. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett 1993 ; 157 (1) : 53-6.
39. ROSSETTI ZL, PANI L, PORTAS C, GESSA G. Brain dialysis provides evidence for D2-dopamine receptors modulating noradrenaline release in the rat frontal cortex. Eur J Pharmacol 1989 ; 163 : 393-5.
40. SAWAGUCHI T, GOLDMAN-RAKIC PS. D1 receptors in prefrontal cortex : involvement in working memory. Science 1991 ; 251 : 947-50.
41. SESACK SR, PICKEL VM. Prefrontal cortical efferent in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neural 1992 ; 320 : 145-60.
42. SEEMAN P, LEE T, CHAU-WONG M, WONG K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (London) 1976 ; 261 : 717-9.
43. SNYDER SH. Phencyclidine. Nature (London) 1980 ; 285 : 355-6.
44. TASSIN JP. Les méthodes en neurobiologie. Encycl Med Chir (Paris, France), Psychiatrie 1986 ; 37037 A10, 9-1986, 16 p.
45. TASSIN JP. Peut-on trouver un lien entre l'inconscient psychanalytique et les connaissances actuelles en neurobiologie ? Neuro-Psy 1989 ; 4 : 421-34.
46. TASSIN JP. NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators in schizophrenia. J Neural Transm 1992 : 36 (suppl.) : 135-62.
47. TASSIN JP. Schizophrénie et Neurotransmission. In : La schizophrénie, recherches actuelles et perspectives. Daléry J, d'Amato T, éds. Paris : Masson, 1995 : 153-74.
48. TASSIN JP, SIMON H, GLOWINSKI J, BOCKAERT J. Modulations of the sensitivity of dopaminergic receptors in the prefrontal cortex and the nucleus accumbens ; relationship with locomotor hyperactivity. In : Brain peptides and hormones, Collu R et al., eds. New-York : Raven Press, 1982.
49. TROVERO F, BLANC G, HERVE D et al. Contribution of an alpha 1-adrenergic receptor to the expression of the « ventral tegmental area syndrom ». Neuroscience 1992 ; 47 : 69-76.
50. VAN KAMMEN DP, ANTELMAN S. Impaired noradrenergic transmission in schizophrenia ? Life Sci 1984 ; 34 : 1403-13.
51. VAN KAMMEN DP, VAN KAMMEN WB, MANN LS et al. Dopamine metabolism in cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Arch Gen Psychiatry 1986 ; 43 : 978-83.
52. VEZINA P, BLANC G, GLOWINSKI J et al. Opposed behavioral outputs of increased dopamine transmission in prefrontocortical and subcortical areas : a role for cortical D1 receptor. Eur J Neurosci 1991 ; 3 : 1001-7.
53. WEINBERGER DR, BERMAN KF, ZEC RF. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional blood flow evidence. Arch Gen Psychiatry 1986 ; 43 : 114-24.
54. WEINER I, LUBOW RE, FELDON J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 1988 ; 30 (4) : 871-8.
55. WONG DF, WAGNER HN, TUNE LE et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986 ; 234 : 1558-63.